Genpact Limited Stock Rises 15.3% Since Reporting Q3 Earnings Beat

12.11.25 14:11 Uhr

Werte in diesem Artikel
Aktien

37,07 EUR -0,57 EUR -1,51%

Genpact Limited G reported impressive third-quarter 2025 results as both earnings and revenues beat the Zacks Consensus Estimate.The better-than-expected results and strong guidance positively impacted the market as the stock has rallied 15.3% since the earnings release on Nov. 6.For the fourth quarter of 2025, Genpact expects adjusted earnings per share (EPS) to be in the range of $93 to $94. The Zacks Consensus Estimate is pegged at 93 cents. For 2025, adjusted EPS is anticipated in the range of $3.60 to $3.61, up from the prior range of $3.51-$3.58. The Zacks Consensus Estimate is pinned at $3.55.For 2025, revenues are anticipated between $5.059 billion and $5.071 billion, up from the prior view of $4.958-$5.053 billion. This represents year-over-year growth of approximately 6.1-6.4% on a reported basis and 5.9-6.2% on a constant currency basis,up from the prior guidance of approximately 4.0% to 6.0%, as reported. The Zacks Consensus Estimate is pegged at $3.55 billion. Quarterly EPS of 97 cents surpassed the consensus estimate by 7.8% and grew 14% year over year. Revenues of $1.29 billion beat the consensus mark by 2.1% and increased 6.6% from the year-ago quarter.Genpact Limited Price, Consensus and EPS Surprise Genpact Limited price-consensus-eps-surprise-chart | Genpact Limited QuoteOther Quarterly Details of GData-Tech-AI services revenues (representing 48.2% of total revenues) increased 9.3% year over year on a reported basis and 8.9% on a constant-currency basis to $622.4 million, surpassing our estimate of $607.6 million. Digital Operations services revenues of $668.9 million (51.8% of total revenues) rose 4.3% from the year-ago quarter’s actuals on a reported basis and 3.4% at cc, beating our estimate of $656.6 million.Adjusted income from operations totaled $228.9 million and grew 7.5% on a year-over-year basis. The adjusted operating income margin of 17.7% increased by 10 basis points on a year-over-year basis.Genpact exited the quarter with cash and cash equivalents of $740.76 million compared with $1.02 billion reported at the end of the September-end quarter of 2024. Long-term debt (less current portion) was $827.05 million.The company generated $308 million in cash from operating activities, while capital expenditure was $19.22 million. Genpact returned $29.29 million in dividends to shareholders and repurchased shares worth $90 million.Guidance by GFor the fourth quarter of 2025, revenues are anticipated between $1.298 billion and $1.311 billion. Representing year-over-year growth of approximately 4.0% to 5.0% as reported, or 3.3% to 4.3% on a constant currency basis.Gross margin is expected to be approximately 36.4%. Adjusted income from operations marginis projected to be approximately 17.4%.For 2025, gross margin is expected to be approximately 36%. Adjusted income from operations margin of approximately 17.4%.Currently, Genpact carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Earnings SnapshotOmnicom Group Inc. OMC reported impressive third-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.Earnings of $2.15 per share beat the consensus estimate by 4.2% and increased 10.3% year over year. Total revenues of $4.04 billion surpassed the consensus estimate by 0.4% and rose 4% year over year. The increase in the top line was led by a 2.6% jump in revenues from organic growth.ManpowerGroup, Inc. MAN posted impressive third-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.Quarterly adjusted earnings per share came in at 83 cents, which beat the Zacks Consensus Estimate by 1.2% but decreased 35.7% year over year. Total revenues of $4.63 billion surpassed the consensus estimate by 0.6% and rose 2.3% year over year.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ManpowerGroup Inc. (MAN): Free Stock Analysis Report Omnicom Group Inc. (OMC): Free Stock Analysis Report Genpact Limited (G): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Genpact

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Genpact

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Genpact LtdShs

Wer­bung

Analysen zu Genpact LtdShs

DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
11.04.2016Genpact UnderperformRBC Capital Markets
DatumRatingAnalyst
08.08.2019Genpact BuyNeedham & Company, LLC
14.06.2019Genpact BuyNeedham & Company, LLC
04.08.2017Genpact Market PerformBMO Capital Markets
29.08.2011Genpact outperformOppenheimer & Co. Inc.
19.05.2011Genpact outperformOppenheimer & Co. Inc.
DatumRatingAnalyst
04.08.2017Genpact NeutralWedbush Morgan Securities Inc.
02.03.2015Genpact HoldDeutsche Bank AG
05.02.2015Genpact HoldDeutsche Bank AG
DatumRatingAnalyst
11.04.2016Genpact UnderperformRBC Capital Markets
30.07.2010Genpact sellKaufman Bros., LP

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Genpact LtdShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen